Aspen Pharmacare Holdings Ltd Cash Flow-to-Debt Ratio
Aspen Pharmacare Holdings Ltd cash flow-to-debt ratio. Aspen Pharmacare Holdings Ltd (APN) has a Cash Flow-to-Debt Ratio of 0.08x as of December 2025, meaning its operating cash flow of ZAC3.58 Billion could theoretically repay 0% of its total liabilities (ZAC46.96 Billion) in one year. Check total reinvestment intensity of Aspen Pharmacare Holdings Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Aspen Pharmacare Holdings Ltd (2003–2025)
Cash flow-to-debt ratio of Aspen Pharmacare Holdings Ltd from 2003 to 2025. Historical debt coverage capacity for Aspen Pharmacare Holdings Ltd across 23 annual periods. Check Aspen Pharmacare Holdings Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Aspen Pharmacare Holdings Ltd Cash Flow-to-Debt Ratio by Year (2003–2025)
Aspen Pharmacare Holdings Ltd cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for Aspen Pharmacare Holdings Ltd. For the full cash flow conversion analysis, see APN cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (ZAC) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | ZAC5.16 Billion | ZAC51.00 Billion | ▼ -11.8% |
| 2024 | 0.11x | ZAC6.22 Billion | ZAC54.29 Billion | ▼ -0.2% |
| 2023 | 0.11x | ZAC5.52 Billion | ZAC48.05 Billion | ▼ -13.6% |
| 2022 | 0.13x | ZAC5.37 Billion | ZAC40.43 Billion | ▼ -14.2% |
| 2021 | 0.15x | ZAC6.83 Billion | ZAC44.06 Billion | ▲ +19.9% |
| 2020 | 0.13x | ZAC8.26 Billion | ZAC63.95 Billion | ▲ +46.6% |
| 2019 | 0.09x | ZAC6.00 Billion | ZAC68.10 Billion | ▲ +3.9% |
| 2018 | 0.08x | ZAC7.02 Billion | ZAC82.74 Billion | ▼ -4.5% |
| 2017 | 0.09x | ZAC6.50 Billion | ZAC73.20 Billion | ▲ +71.5% |
| 2016 | 0.05x | ZAC3.20 Billion | ZAC61.80 Billion | ▼ -41.9% |
| 2015 | 0.09x | ZAC4.84 Billion | ZAC54.26 Billion | ▲ +24.8% |
| 2014 | 0.07x | ZAC3.84 Billion | ZAC53.67 Billion | ▼ -59.4% |
| 2013 | 0.18x | ZAC3.99 Billion | ZAC22.62 Billion | ▼ -13.2% |
| 2012 | 0.20x | ZAC2.91 Billion | ZAC14.32 Billion | ▲ +12.2% |
| 2011 | 0.18x | ZAC2.45 Billion | ZAC13.51 Billion | ▼ -20.6% |
| 2010 | 0.23x | ZAC2.03 Billion | ZAC8.91 Billion | ▲ +45.8% |
| 2009 | 0.16x | ZAC1.29 Billion | ZAC8.26 Billion | ▲ +80.6% |
| 2008 | 0.09x | ZAC652.38 Million | ZAC7.53 Billion | ▼ -37.1% |
| 2007 | 0.14x | ZAC708.56 Million | ZAC5.14 Billion | ▼ -12.9% |
| 2006 | 0.16x | ZAC402.21 Million | ZAC2.54 Billion | ▼ -49.7% |
| 2005 | 0.31x | ZAC638.20 Million | ZAC2.03 Billion | ▼ -34.2% |
| 2004 | 0.48x | ZAC498.74 Million | ZAC1.04 Billion | ▲ +9.8% |
| 2003 | 0.44x | ZAC385.95 Million | ZAC886.73 Million | — |